Mogam Institute for Biomedical Research
↗Seoul, South Korea
Mogam Institute for Biomedical Research (MIBR) is a premier South Korean non-profit research organization established in 1984 by Dr. Young-sup Huh, the founder of GC Biopharma. Originally founded to localize essential medicines, the institute gained global recognition for developing the world's third hepatitis B vaccine and the first epidemic hemorrhagic fever vaccine.
In January 2022, Mogam underwent a strategic transformation into an AI-driven drug discovery center. It now integrates advanced bioinformatics, machine learning, and wet-lab expertise to accelerate the development of mRNA therapeutics, protein engineering, and treatments for rare and infectious diseases. The institute operates as a core R&D engine for the GC Biopharma group while maintaining independent academic and clinical partnerships.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:AI Drug Discovery & mRNA Therapeutics
SIZE & FINANCIALS
Employees:51-200
Founded:1984
Ownership:nonprofit
Status:operating
FUNDING
Stage:Grant-funded
Investors:GC Biopharma, Ministry of Health and Welfare (South Korea), National Research Foundation of Korea (NRF)
PIPELINE
Stage:Discovery|Preclinical
Lead Drug Stage:Preclinical
Modalities:mRNA, Bispecific T-cell Engager (BiTE), Protein Engineering, mAb, LNP
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:GC Biopharma (Founder/Primary Funder)
Key Partnerships:Seoul National University Hospital (SNUH) - Rare disease knowledge base, Imperial College London - AI drug discovery collaboration, Ministry of Health and Welfare - K-AI New Drug Development Project
COMPETITION
Position:Emerging
Competitors:Standigm, Deargen, AIGENDRUG, Insilico Medicine
LEADERSHIP
Key Executives:
Dr. Hyunjin Shin - President
Dr. Sun Kim - Former President / Advisor
Scientific Founders:Dr. Young-sup Huh
LINKS
Website:mogam.re.kr
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mogam Institute for Biomedical Research. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.